|
Michele M. Wales joined the HGS Intellectual Property department in 1998, and was promoted to Vice President, Intellectual Property, in 2007. Prior to HGS, Dr. Wales was with the intellectual property law firm of Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P., where she began her legal career in 1995. Dr. Wales earned her Ph.D. in human genetics and molecular biology from The Johns Hopkins Medical School, where she did post-doctoral work in the Department of Oncology. She earned her J.D. from George Washington University National Law Center, and her B.S. cum laude in molecular and cellular biology from the University of Connecticut. While at Johns Hopkins, Dr. Wales co-discovered and characterized the novel tumor suppressor gene, HIC-1, which is associated with the development of a number of cancers and for which patents have been granted. | 